Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04536376 · ClinicalTrials.gov registry record · NA

First Responder Resiliency Program During COVID-19

A NA study of Stress and Sleep, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04536376 is a NA study of Stress and Sleep that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04536376, a NA study of Stress and Sleep, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Evaluating a wellness program developed to provide effective sustainable solutions for medical professionals providing care to COVID-19 pandemic patients.

Interventions

  • BEHAVIORAL Resilience Program

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-01-15
Est. Completion 2022-12-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04536376

The ClinicalTrials.gov registry entry for NCT04536376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 152 other Stress trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Resilience Program is the first listed.

NCT04536376 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04536376 about?

NCT04536376 is a clinical study titled "First Responder Resiliency Program During COVID-19". Evaluating a wellness program developed to provide effective sustainable solutions for medical professionals providing care to COVID-19 pandemic patients.

What is the current status of trial NCT04536376?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-01-15. Estimated completion is 2022-12-31.

What conditions does trial NCT04536376 study?

This clinical trial studies the following conditions: Stress, Sleep, Resilience.

What interventions are being tested in trial NCT04536376?

The interventions under investigation include: Resilience Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04536376?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04536376 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.